CHRNA7 and neoplasm: Together, the identification of CHRNA7-regulated chemokines (i.e. NanoString array) and genes (i.e. scRNAseq) established candidate molecular endpoints to better define the role(s) of CHRNA7 in specific myeloid immune cell types involved in adaptive immune responses relevant in tumor progression.